HARTFORD FUNDS > HARTFORD MUTUAL FUNDS INC/CT
THE HARTFORD HEALTHCARE FUND
$1.24B
Avg Monthly Net Assets
$1.10B
Total Assets
$1.56M
Total Liabilities
$1.10B
Net Assets
THE HARTFORD HEALTHCARE FUND is a Mutual Fund in HARTFORD MUTUAL FUNDS INC/CT
from HARTFORD FUNDS,
based in Pennsylvania,
United States of America.
The fund has nine share classes
and monthly net assets of $1.24B.
On September 25th, 2024 it reported 110 holdings, the largest
being Eli Lilly & Co (10.2%), UnitedHealth Group Inc (9.0%) and Danaher Corp (3.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A | C000009932 | HGHAX | |
| Class C | C000009934 | HGHCX | |
| Class F | C000185697 | HGHFX | |
| Class I | C000035170 | HGHIX | |
| Class R3 | C000040933 | HGHRX | |
| Class R4 | C000040934 | HGHSX | |
| Class R5 | C000040935 | HGHTX | |
| Class R6 | C000211746 | HGHVX | |
| Class Y | C000009935 | HGHYX |
Holdings
From latest NPORT-P, filed September 25th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| Abbott Laboratories | Long | Equity-common | US | $6M | 60K | 0.57 |
| AbbVie Inc | Long | Equity-common | US | $21M | 111K | 1.88 |
| Acadia Healthcare Co Inc | Long | Equity-common | US | $14M | 216K | 1.27 |
| Addus HomeCare Corp | Long | Equity-common | US | $6M | 52K | 0.57 |
| Agilent Technologies Inc | Long | Equity-common | US | $14M | 96K | 1.23 |
| agilon health Inc | Long | Equity-common | US | $5M | 788K | 0.49 |
| Akero Therapeutics Inc | Long | Equity-common | US | $3M | 123K | 0.30 |
| Align Technology Inc | Long | Equity-common | US | $5M | 22K | 0.46 |
| Alkermes PLC | Long | Equity-common | IE | $4M | 145K | 0.36 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $8M | 34K | 0.73 |
| Amgen Inc | Long | Equity-common | US | $5M | 14K | 0.42 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $4M | 93K | 0.33 |
| Ardent Health Partners LLC | Long | Equity-common | US | $5M | 271K | 0.44 |
| Argenx SE | Long | Equity-common | NL | $13M | 25K | 1.19 |
| Ascendis Pharma A/S | Long | Equity-common | DK | $5M | 40K | 0.48 |
| Astellas Pharma Inc | Long | Equity-common | JP | $8M | 655K | 0.69 |
| AstraZeneca PLC | Long | Equity-common | GB | $22M | 273K | 1.97 |
| Autolus Therapeutics PLC | Long | Equity-common | GB | $2M | 496K | 0.21 |
| Avidity Biosciences Inc | Long | Equity-common | US | $5M | 108K | 0.45 |
| Bio-Techne Corp | Long | Equity-common | US | $4M | 48K | 0.35 |
| Biogen Inc | Long | Equity-common | US | $8M | 38K | 0.75 |
| Blueprint Medicines Corp | Long | Equity-common | US | $3M | 29K | 0.29 |
| Boston Scientific Corp | Long | Equity-common | US | $34M | 464K | 3.12 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $2M | 74K | 0.18 |
| Celldex Therapeutics Inc | Long | Equity-common | US | $5M | 132K | 0.46 |
| Cencora Inc | Long | Equity-common | US | $22M | 92K | 1.99 |
| Centene Corp | Long | Equity-common | US | $16M | 211K | 1.48 |
| Chugai Pharmaceutical Co Ltd | Long | Equity-common | JP | $8M | 188K | 0.75 |
| CITIBANK NA DDCA | Long | Short-term investment vehicle | US | $10K | 10K | 0.00 |
| CONTRA ABIOMED INC | Derivative-equity | US | $8K | 7K | 0.00 | |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $6M | 104K | 0.50 |
| Cytokinetics Inc | Long | Equity-common | US | $5M | 81K | 0.44 |
| Daiichi Sankyo Co Ltd | Long | Equity-common | JP | $13M | 313K | 1.16 |
| Danaher Corp | Long | Equity-common | US | $41M | 149K | 3.77 |
| Dexcom Inc | Long | Equity-common | US | $10M | 141K | 0.87 |
| DiaSorin SpA | Long | Equity-common | IT | $4M | 40K | 0.40 |
| Disc Medicine Inc | Long | Equity-common | US | $3M | 67K | 0.26 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $15M | 241K | 1.38 |
| Eisai Co Ltd | Long | Equity-common | JP | $6M | 167K | 0.58 |
| Elanco Animal Health Inc | Long | Equity-common | US | $6M | 431K | 0.51 |
| Elevance Health Inc | Long | Equity-common | US | $8M | 15K | 0.73 |
| Eli Lilly & Co | Long | Equity-common | US | $112M | 139K | 10.16 |
| Encompass Health Corp | Long | Equity-common | US | $8M | 86K | 0.73 |
| Evolent Health Inc | Long | Equity-common | US | $6M | 278K | 0.59 |
| Exact Sciences Corp | Long | Equity-common | US | $4M | 91K | 0.38 |
| FIXED INC CLEARING CORP.REPO (Fixed Income Clearing Corp.) | Long | Repurchase agreement | US | $2M | – | 0.20 |
| Galderma Group AG | Long | Equity-common | CH | $12M | 150K | 1.07 |
| Genmab A/S | Long | Equity-common | DK | $3M | 10K | 0.26 |
| Genus PLC | Long | Equity-common | GB | $2M | 100K | 0.21 |
| Glaukos Corp | Long | Equity-common | US | $6M | 53K | 0.57 |
| Goldman Sachs Financial Square Funds - Government Fund | Long | Short-term investment vehicle | US | $29K | 29K | 0.00 |
| GSK PLC | Long | Equity-common | GB | $8M | 413K | 0.73 |
| HCA Healthcare Inc | Long | Equity-common | US | $24M | 66K | 2.17 |
| Hologic Inc | Long | Equity-common | US | $9M | 107K | 0.80 |
| HSBC U.S. Government Money Market Fund | Long | Short-term investment vehicle | US | $95K | 95K | 0.01 |
| Humana Inc | Long | Equity-common | US | $17M | 46K | 1.51 |
| ICON PLC | Long | Equity-common | IE | $13M | 41K | 1.22 |
| Immatics NV | Long | Equity-common | NL | $4M | 313K | 0.34 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $3M | 85K | 0.31 |
| Inspire Medical Systems Inc | Long | Equity-common | US | $3M | 18K | 0.23 |
| Insulet Corp | Long | Equity-common | US | $7M | 37K | 0.66 |
| Intuitive Surgical Inc | Long | Equity-common | US | $14M | 32K | 1.30 |
| Invesco Government & Agency Portfolio | Long | Short-term investment vehicle | US | $29K | 29K | 0.00 |
| Kymera Therapeutics Inc | Long | Equity-common | US | $3M | 72K | 0.30 |
| Labcorp Holdings Inc | Long | Equity-common | US | $9M | 43K | 0.85 |
| Legend Biotech Corp | Long | Equity-common | KY | $2M | 39K | 0.20 |
| LifeStance Health Group Inc | Long | Equity-common | US | $5M | 887K | 0.45 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $3M | 101K | 0.30 |
| Merck & Co Inc | Long | Equity-common | US | $40M | 354K | 3.64 |
| Merus NV | Long | Equity-common | NL | $4M | 71K | 0.34 |
| Moderna Inc | Long | Equity-common | US | $3M | 29K | 0.31 |
| Molina Healthcare Inc | Long | Equity-common | US | $10M | 30K | 0.94 |
| MoonLake Immunotherapeutics | Long | Equity-common | KY | $2M | 54K | 0.20 |
| Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Morgan Stanley & Co. LLC) | Long | Short-term investment vehicle | US | $29K | 29K | 0.00 |
| Natera Inc | Long | Equity-common | US | $2M | 20K | 0.19 |
| Novartis AG | Long | Equity-common | CH | $5M | 47K | 0.47 |
| Novo Nordisk A/S | Long | Equity-common | DK | $10M | 73K | 0.89 |
| Nuvalent Inc | Long | Equity-common | US | $3M | 34K | 0.25 |
| Option Care Health Inc | Long | Equity-common | US | $7M | 220K | 0.59 |
| Otsuka Holdings Co Ltd | Long | Equity-common | JP | $8M | 163K | 0.76 |
| PACS Group Inc | Long | Equity-common | US | $4M | 103K | 0.34 |
| Pfizer Inc | Long | Equity-common | US | $11M | 372K | 1.04 |
| Privia Health Group Inc | Long | Equity-common | US | $4M | 202K | 0.38 |
| PTC Therapeutics Inc | Long | Equity-common | US | $3M | 79K | 0.24 |
| QIAGEN NV | Long | Equity-common | NL | $5M | 124K | 0.50 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $20M | 19K | 1.82 |
| Repligen Corp | Long | Equity-common | US | $6M | 34K | 0.52 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $6M | 141K | 0.58 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $4M | 160K | 0.35 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $6M | 41K | 0.53 |
| Savara Inc | Long | Equity-common | US | $3M | 724K | 0.30 |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Long | Equity-common | CN | $3M | 143K | 0.26 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $3M | 72K | 0.31 |
| Structure Therapeutics Inc | Long | Equity-common | KY | $4M | 111K | 0.38 |
| Stryker Corp | Long | Equity-common | US | $25M | 77K | 2.29 |
| Surgery Partners Inc | Long | Equity-common | US | $5M | 170K | 0.47 |
| Syndax Pharmaceuticals Inc | Long | Equity-common | US | $3M | 148K | 0.31 |
| Tecan Group AG | Long | Equity-common | CH | $4M | 10K | 0.33 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $34M | 55K | 3.08 |
| UCB SA | Long | Equity-common | BE | $8M | 46K | 0.70 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $4M | 89K | 0.37 |
| United Therapeutics Corp | Long | Equity-common | US | $8M | 24K | 0.70 |
| UnitedHealth Group Inc | Long | Equity-common | US | $99M | 172K | 9.03 |
| Vaxcyte Inc | Long | Equity-common | US | $5M | 61K | 0.44 |
| Veracyte Inc | Long | Equity-common | US | $3M | 138K | 0.30 |
| Verona Pharma PLC | Long | Equity-common | GB | $4M | 186K | 0.38 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $29M | 59K | 2.67 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $4M | 96K | 0.38 |
| Zai Lab Ltd | Long | Equity-common | KY | $2M | 103K | 0.18 |
| Zoetis Inc | Long | Equity-common | US | $20M | 113K | 1.85 |
Address
HARTFORD MUTUAL FUNDS INC/CT
690 LEE ROAD
WAYNE
Pennsylvania
19087
United States of America
Websites
Directors
Paul L. Rosenberg
James E. Davey
Andrew A. Johnson
Robin C. Beery
Derrick D. Cephas
Hilary E. Ackermann
Christine R. Detrick
David Sung
John J. Gauthier
Transfer Agents
Hartford Administrative Services Company
Pricing Services
Refinitiv US Holdings Inc.
Bloomberg L.P.
PricingDirect Inc.
ICE Data Services, Inc.
S&P Global Inc.
Custodians
FirstRand Bank Limited
Royal Bank of Canada
State Street Trust Company Canada
Intesa Sanpaolo S.p.A.
UBS Switzerland AG
Citibank, National Association (Singapore, SG, Branch)
Skandinaviska Enskilda Banken AB (Helsinki, Uusimaa, FI, Branch)
Euroclear Bank
HSBC Bank Bermuda Limited
State Street Bank and Trust Company (Edinburgh, GB, Branch)
Skandinaviska Enskilda Banken AB (Oslo, Oslo, NO, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Sydney, NSW, AU, Branch)
Citibank Europe Public Limited Company (Budapest, HU, Branch)
Standard Chartered Bank (Makati City, Metro Manila, PH, Branch)
Citibank Europe Public Limited Company
Skandinaviska Enskilda Banken A/S
UniCredit Bank Austria AG
Standard Chartered Bank (Thai) Public Company Limited
The Hongkong and Shanghai Banking Corporation Limited (Chuo ku, Tokyo, JP, Branch)
State Street Bank International GmbH
The Hongkong and Shanghai Banking Corporation Limited (Auckland, Auckland, NZ, Branch)
Ceskoslovenska obchodni banka, a. s.
The Hongkong and Shanghai Banking Corporation Limited
State Street Bank and Trust Company
Banco Nacional de Mexico, S.A., Integrante del Grupo Financiero Banamex
BNP Paribas
Standard Chartered Bank (Jakarta, Jakarta, ID, Branch)
Shareholder Servicing Agents
Hartford Administrative Services Company
Admins
Hartford Funds Management Company, LLC
Brokers
Goldman Sachs & Co. LLC
Jefferies LLC
Barclays Capital Inc.